News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hoerter Steven L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 7,500 shares
@ $15.5709, valued at
$116.8k
|
|
| 06/17/2022 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 50,283 options to buy
@ $3.75, valued at
$188.6k
|
|
| 03/23/2022 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 3,150 shares
@ $9.11, valued at
$28.7k
|
|
| 01/20/2022 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 415,000 options to buy
@ $8.27, valued at
$3.4M
|
|
| 12/17/2021 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 270,357 options to buy
@ $9.23, valued at
$2.5M
|
|
| 08/16/2021 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 33,250 options to buy
@ $18.63, valued at
$619.4k
|
|
| 08/16/2021 |
3
| Hoerter Steven L. (Director) has filed a Form 3 on Oric Pharmaceuticals, Inc. |
| 07/23/2021 |
4/A
| Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 26,342 options to buy
@ $9.05, valued at
$238.4k
|
|
| 07/19/2021 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 13,171 options to buy
@ $33.57, valued at
$442.2k
Disposed/sold 13,171 options to buy
@ $9.12, valued at
$120.1k
Disposed/sold 26,342 options to buy
@ $7.6, valued at
$200.2k
Disposed/sold 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 700 shares
@ $42.3886, valued at
$29.7k
Paid exercise price by delivering 2,450 shares
@ $43.1949, valued at
$105.8k
|
|
| 02/18/2021 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 210,000 options to buy
@ $47.79, valued at
$10M
|
|
| 01/25/2021 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 1,078 options to buy
@ $25.4, valued at
$27.4k
|
|
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
| 06/01/2020 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 188 shares
@ $25.4, valued at
$4.8k
Granted 188 options to buy
@ $25.4, valued at
$4.8k
|
|
| 04/23/2020 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 187 shares
@ $25.4, valued at
$4.7k
Granted 187 options to buy
@ $25.4, valued at
$4.7k
|
|
| 03/20/2020 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 2,250 shares
@ $25.4, valued at
$57.2k
Paid exercise price by delivering 4,494 shares
@ $35.78, valued at
$160.8k
Paid exercise price by delivering 1,012 shares
@ $36.88, valued at
$37.3k
Paid exercise price by delivering 4,230 shares
@ $38.26, valued at
$161.8k
Paid exercise price by delivering 2,164 shares
@ $39.22, valued at
$84.9k
Paid exercise price by delivering 520 shares
@ $39.98, valued at
$20.8k
Granted 2,250 options to buy
@ $25.4, valued at
$57.2k
|
|
| 02/20/2020 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 180,000 options to buy
@ $54.87, valued at
$9.9M
|
|
| 06/10/2019 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 13,171 options to buy
@ $9.12, valued at
$120.1k
|
|
| 03/20/2019 |
4
| Hoerter Steven L. (President & CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 22,000 shares
@ $0
Granted 30,000 shares
@ $0
Granted 400,000 options to buy
@ $25.4, valued at
$10.2M
|
|
| 03/05/2019 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $66.01, valued at
$330.1k
Sold 5,000 shares
@ $68, valued at
$340k
Exercised 5,000 options to buy
@ $39.76, valued at
$198.8k
Exercised 5,000 options to buy
@ $39.76, valued at
$198.8k
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,769 shares
@ $52.82, valued at
$304.7k
Exercised 15,000 options to buy
@ $0 |
|
| 09/05/2018 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 26,342 options to buy
@ $9.05, valued at
$238.4k
|
|
| 09/05/2018 |
3
| Hoerter Steven L. (Director) has filed a Form 3 on CONSTELLATION PHARMACEUTICALS INC |
| 08/28/2018 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,050 shares
@ $74.92, valued at
$153.6k
Exercised 2,050 options to buy
@ $39.76, valued at
$81.5k
|
|
| 07/27/2018 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,050 shares
@ $84.58, valued at
$173.4k
Exercised 2,050 options to buy
@ $39.76, valued at
$81.5k
|
|
| 07/24/2018 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 06/26/2018 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,050 shares
@ $97.58, valued at
$200k
Exercised 2,050 options to buy
@ $39.76, valued at
$81.5k
|
|
| 05/29/2018 |
4
| Hoerter Steven L. (Chief Commercial Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,050 shares
@ $85.76, valued at
$175.8k
Exercised 2,050 options to buy
@ $39.76, valued at
$81.5k
|
|
| 05/21/2018 |
4
| Hoerter Steven L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 24,000 options to buy
@ $25.73, valued at
$617.5k
|
|
|
|
|